The syndrome of bilateral basal ganglia lesions in diabetic uremic patients presenting with a relapsing and remitting course: A case report

Acta Neurologica Taiwanica

Volumn 16, Issue 4, 2007, Pages 226-230

  Sheu, Yu Lin ^a   Cheng, Shin Jung ^a   Chen, Yi Min ^a   Hseuh, I Hung ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Basal ganglia; Diabetes mellitus; Encephalomalasia; Parkinsonism; Uremia

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE COURSE; ENCEPHALOMALACIA; HUMAN; LABORATORY TEST; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; THORAX RADIOGRAPHY; UREMIA;

BASAL GANGLIA DISEASES; DIABETIC NEPHROPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; UREMIA;

EID: 37549052089     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wang HC, Cheng SJ. The syndrome of acute bilateral basal ganglia lesions in diabetic uremic patients. J Neurol 2003; 250:948-55.
2. Wang HC, Brown P, Lees AJ. Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord 1998;13:952-7.
3. Kim TK, Seo SI, Kim JH, et al. Diffusion-weighted magnetic resonance imaging in the syndrome of acute bilateral basal ganglia lesions in diabetic uremia. Mov Disord 2006;21:1267-70.
4. Wang HC, Hsu JL, Shen YY. Acute bilateral basal ganglia lesions in patients with diabetic uremia: an FDG-PET study. Clin Nucl Med 2004;29:475-8.
5. Lee YH. Diabetic nephropathy with acute symmetrical changes in the basal ganglia regions. Clin Radiol 2005;60: 815-20.
6. Lee PH, Shin DH, Kim JW, et al. Parkinsonism with basal ganglia lesions in a patient with uremia: evidence of vasogenic edema. Parkinsonism Relat Disord 2006;12:93-6.
7. Cupidi C, Piccoli F, La Bella V. Acute reversible parkinsonism in a diabetic-uremic patient. Clin Neurol Neurosurg 2006;108:601-3.
8. Tzamaloukas AH, Agaba EI. Neurological manifestations of uremia and chronic dialysis. Niger J Med 2004;13:98-105.
9. Fraser CL, Arieff AI. Nervous system complications in uremia. Ann Intern Med 1988;109:143-53.
10. Ohtsuki S, Asaba H, Takanaga H, et al. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 2002;83:57-66.
11. Deguchi T, Isozaki K, Yousuke K, et al. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier. J Neurochem 2006;96:1051-9.
12. Port JD, Beauchamp NJ Jr. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 1998;18:353-67.
13. Kwok RP, Juorio AV. Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration. Neuroendocrinology 1986;43:590-6.